D9-Tetrahydrocannabinol (THC) – Medical Marijuana

Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo

Treatment of Tourette-Syndrome with D9-Tetrahydrocannabinol (THC)- a randomized crossover trial

The endocannabinoid system and emotional Processing- A pharmacological fMRI study with D9-tetrahydrocannabinol

The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids- Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

Russo_A tale of two cannabinoids

Protective effects of Δ9-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death

Preliminary, open-label, pilot study of add-on oral D9-tetrahydrocannabinol in chronic post-traumatic stress disorder

Opposite Effects of D-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-d-Aspartate-Induced Retinal Neurotoxicity